| Code | CSB-RA044921A0HU |
| Size | US$210 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
| Application | Recommended Dilution |
|---|---|
| IHC | 1:50-1:200 |
| FC | 1:50-1:200 |
ARAF (A-Raf proto-oncogene, serine/threonine kinase) functions as a critical upstream activator in the MAPK/ERK signaling cascade, playing essential roles in cell proliferation, differentiation, and survival. As one of three RAF family kinases, ARAF contributes to signal transduction from cell surface receptors to the nucleus, making it a significant target for researchers investigating oncogenic signaling pathways, developmental biology, and therapeutic resistance mechanisms in cancer.
This recombinant monoclonal antibody, clone 18D4, offers the reproducibility and consistency that demanding research applications require. Generated against a synthetic peptide derived from human ARAF protein, the antibody is produced using recombinant technology, ensuring sequence-defined specificity and eliminating the lot-to-lot variability often encountered with traditional hybridoma-derived antibodies. This consistency is particularly valuable for longitudinal studies or multi-site collaborations where experimental reproducibility is paramount.
Validation testing demonstrates reliable performance across multiple platforms. Immunohistochemistry studies confirm clear detection in paraffin-embedded human cervical cancer and thyroid tissue sections at 1:100 dilution using citrate buffer antigen retrieval, providing researchers flexibility when examining ARAF expression patterns in clinical specimens. Flow cytometry analysis using HeLa cells shows distinct positive signal separation from isotype control, enabling quantitative assessment of ARAF levels in cell populations at dilutions between 1:50 and 1:200.
The unconjugated format and affinity-purified rabbit IgG preparation allow integration into existing detection workflows using standard secondary antibody systems. Supplied in a glycerol-containing buffer for optimal stability, this antibody serves researchers exploring RAF-MEK-ERK pathway dynamics, tumor progression mechanisms, and targeted therapy development.
There are currently no reviews for this product.